We are live on !
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
Turnover
15.26%
1-Year Est. Return
41.24%
This Quarter Est. Return
+25.64%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$69.2B
AUM Growth
+$1.61B
(+2.4%)
Cap. Flow
-$7.07B
Cap. Flow % of AUM
Cap. Flow %
-10.23%
Top 10 Holdings %
Top 10 Hldgs %
46.63%
Holding
2,045
New
180
Increased
582
Reduced
1,148
Closed
132
Avg Time Held
6.4
years
Top 10 Avg Time Held
5.6
years
Top 20 Avg Time Held
5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$199M |
| 2 |
Sandisk
SNDK
|
+$197M |
| 3 |
Genuine Parts
GPC
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$134M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$76.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares GENIUS Money Market ETF
IQMM
|
+$876M |
| 2 |
NVIDIA
NVDA
|
+$678M |
| 3 |
Apple
AAPL
|
+$472M |
| 4 |
Microsoft
MSFT
|
+$341M |
| 5 |
Micron Technology
MU
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.21% |
| 2 | Miscellaneous | 27.25% |
| 3 | Industrials | 6.93% |
| 4 | Consumer Staples | 6.67% |
| 5 | Consumer Discretionary | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
Ready Capital
RC
$195M
| $33.3K | ﹤0.01% |
19,018
-2,212
| -10% | -$3.89K |
2021 Q4
18 quarters
|
|
1877
Neumora Therapeutics
NMRA
$71.2M
| $33.2K | ﹤0.01% |
+19,508
| New | +$37.1K |
2026 Q2
0 quarters
|
|
1878
Eve Holding
EVEX
$561M
| $32.7K | ﹤0.01% |
13,023
-875
| -6% | -$2.52K |
2025 Q4
2 quarters
|
|
1879
Gogo Inc
GOGO
$318M
| $32.6K | ﹤0.01% |
10,507
-1,644
| -14% | -$6.7K |
2023 Q4
10 quarters
|
|
1880
Invivyd
IVVD
$182M
| $32.5K | ﹤0.01% |
37,220
+24,824
| +200% | +$31.1K |
2025 Q4
2 quarters
|
|
1881
Microvast
MVST
$213M
| $32.4K | ﹤0.01% |
27,694
-1,150
| -4% | -$1.77K |
2025 Q2
4 quarters
|
|
1882
Codexis
CDXS
$141M
| $32.3K | ﹤0.01% |
14,303
-2,673
| -16% | -$6.65K |
2024 Q3
7 quarters
|
|
1883
Inhibikase Therapeutics
IKT
$219M
| $32.3K | ﹤0.01% |
15,895
+358
| +2% | +$641 |
2025 Q2
4 quarters
|
|
1884
Outdoor Holding Co
POWW
$276M
| $32.1K | ﹤0.01% |
14,092
-1,259
| -8% | -$2.59K |
2022 Q4
14 quarters
|
|
1885
SES AI
SES
$288M
| $31.7K | ﹤0.01% |
+33,004
| New | +$35.9K |
2026 Q2
0 quarters
|
|
1886
Lineage Cell Therapeutics
LCTX
$260M
| $31.6K | ﹤0.01% |
+24,129
| New | +$33.3K |
2026 Q2
0 quarters
|
|
1887
8x8 Inc
EGHT
$319M
| $31.2K | ﹤0.01% |
18,262
-1,641
| -8% | -$3.3K |
2020 Q2
24 quarters
|
|
1888
Coherus Oncology
CHRS
$176M
| $31K | ﹤0.01% |
22,172
+472
| +2% | +$771 |
2015 Q4
42 quarters
|
|
1889
Sidus Space
SIDU
$113M
| $30.3K | ﹤0.01% |
+10,790
| New | +$41.4K |
2026 Q2
0 quarters
|
|
1890
Claros Mortgage Trust
CMTG
$168M
| $29.6K | ﹤0.01% |
12,608
-775
| -6% | -$1.9K |
2022 Q2
16 quarters
|
|
1891
ALX Oncology
ALXO
$149M
| $29.2K | ﹤0.01% |
+14,125
| New | +$25.3K |
2026 Q2
0 quarters
|
|
1892
Ribbon Communications
RBBN
$256M
| $28.7K | ﹤0.01% |
12,277
-1,320
| -10% | -$3.48K |
2023 Q2
12 quarters
|
|
1893
Conduent
CNDT
$244M
| $27.5K | ﹤0.01% |
18,842
-1,581
| -8% | -$2.46K |
2019 Q3
27 quarters
|
|
1894
Goldgroup Mining
GORO
$559M
| $27.2K | ﹤0.01% |
+5,399
| New | +$29.5K |
2026 Q2
0 quarters
|
|
1895
Ring Energy
REI
$367M
| $27.1K | ﹤0.01% |
+25,092
| New | +$35K |
2026 Q2
0 quarters
|
|
1896
Caribou Biosciences
CRBU
$49.8M
| $26.9K | ﹤0.01% |
+15,279
| New | +$30.2K |
2026 Q2
0 quarters
|
|
1897
SmartRent
SMRT
$251M
| $26.7K | ﹤0.01% |
+22,406
| New | +$28.5K |
2026 Q2
0 quarters
|
|
1898
Holley
HLLY
$313M
| $26.1K | ﹤0.01% |
10,238
-838
| -8% | -$2.38K |
2024 Q4
6 quarters
|
|
1899
Alector
ALEC
$245M
| $25.8K | ﹤0.01% |
12,848
-340
| -3% | -$729 |
2019 Q4
26 quarters
|
|
1900
American Resources Corp
AREC
$127M
| $25K | ﹤0.01% |
+11,615
| New | +$26K |
2026 Q2
0 quarters
|
|
Similar funds
ProShare Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, ProShare Advisors held 2,045 positions worth $69.2B, up 2.4% from $67.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
ProShare Advisors withdrew a net $7.07B in Q2 2026, closing 132 positions and reducing 1,148 holdings. Its most notable exit was Atlassian, an estimated $14.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Industrials.
Against the trend, ProShare Advisors opened a new position in Honeywell Aerospace worth $76.5M.
- ProShare Advisors's largest Q2 2026 buy was Honeywell Aerospace: 346,243 shares worth $76.5M.
- ProShare Advisors added most to General Dynamics in Q2 2026, an estimated $199M increase.
- ProShare Advisors's biggest Q2 2026 reduction was ProShares GENIUS Money Market ETF, cutting an estimated $876M.
- ProShare Advisors fully exited Atlassian in Q2 2026, selling an estimated $14.7M.
- ProShare Advisors's ten largest holdings make up 47% of its $69.2B portfolio in Q2 2026.
- ProShare Advisors opened 180 new positions and closed 132 in Q2 2026.
- ProShare Advisors's portfolio value rose 2.4% quarter-over-quarter to $69.2B.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.